» Articles » PMID: 21587099

Trends in the Diagnosis of Rett Syndrome in Australia

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2011 May 19
PMID 21587099
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Modifications to diagnostic criteria and introduction of genetic testing have likely affected the pattern and timing of Rett syndrome diagnosis. The trends in incidence and prevalence of Rett syndrome in Australia were examined; the cumulative risk of a female being diagnosed was determined; and the impact of changes to diagnostic criteria and availability of genetic testing on these frequencies was investigated. The population-based Australian Rett Syndrome Database was used to identify a total of 349 verified Rett syndrome females born 1976-2006 and diagnosed 1982-2008. The proportion of female cases born and diagnosed per year and the cumulative risk of a diagnosis were determined. The median age of Rett syndrome diagnosis decreased from 4.5 y if diagnosed before 2000 to 3.5 y if diagnosed after 1999. The cumulative risk of diagnosis had almost doubled by 32 y of age [1/8,905 or 11.23 per 100,000 person-years (95% CI, 10.03-12.45)] in comparison with 5 y of age [1/15,361 or 6.51 per 100,000 person-years (95% CI, 5.65-7.39)]. Earlier age of diagnosis may result in families experiencing less stress and emotional strain compared with those with delayed diagnosis.

Citing Articles

Minimally Invasive Bipolar Technique for Scoliosis in Rett Syndrome-Results and Complications in a Series of 22 Cases.

Del Sal A, Haumont E, Pigeolet M, Gaume M, Riouallon G, Bahi Buisson N J Clin Med. 2025; 14(3).

PMID: 39941520 PMC: 11818170. DOI: 10.3390/jcm14030849.


International workshop: what is needed to ensure outcome measures for Rett syndrome are fit-for-purpose for clinical trials? June 7, 2023, Nashville, USA.

Downs J, Pichard D, Kaufmann W, Horrigan J, Raspa M, Townend G Trials. 2024; 25(1):845.

PMID: 39709426 PMC: 11663341. DOI: 10.1186/s13063-024-08678-6.


Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2-4 Years with Rett Syndrome.

Darwish M, Passarell J, Maxwell K, Bradley H, Bishop K, Youakim J Adv Ther. 2024; 42(2):1009-1025.

PMID: 39692837 PMC: 11787236. DOI: 10.1007/s12325-024-03058-7.


Population Pharmacokinetic Modeling to Support Trofinetide Dosing for the Treatment of Rett Syndrome.

Darwish M, Passarell J, Maxwell K, Youakim J, Bradley H, Bishop K Adv Ther. 2024; 42(2):1026-1043.

PMID: 39692836 PMC: 11787235. DOI: 10.1007/s12325-024-03056-9.


Rett syndrome.

Gold W, Percy A, Neul J, Cobb S, Pozzo-Miller L, Issar J Nat Rev Dis Primers. 2024; 10(1):84.

PMID: 39511247 DOI: 10.1038/s41572-024-00568-0.


References
1.
Neul J, Kaufmann W, Glaze D, Christodoulou J, Clarke A, Bahi-Buisson N . Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol. 2010; 68(6):944-50. PMC: 3058521. DOI: 10.1002/ana.22124. View

2.
Pini G, Milan M, Zappella M . Rett syndrome in northern Tuscany (Italy): family tree studies. Clin Genet. 1996; 50(6):486-90. DOI: 10.1111/j.1399-0004.1996.tb02718.x. View

3.
Amir R, Fang P, Yu Z, Glaze D, Percy A, Zoghbi H . Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome. J Med Genet. 2005; 42(2):e15. PMC: 1735975. DOI: 10.1136/jmg.2004.026161. View

4.
Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R . CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet. 2005; 14(14):1935-46. DOI: 10.1093/hmg/ddi198. View

5.
Ariani F, Hayek G, Rondinella D, Artuso R, Mencarelli M, Spanhol-Rosseto A . FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet. 2008; 83(1):89-93. PMC: 2443837. DOI: 10.1016/j.ajhg.2008.05.015. View